Linagliptin, the active ingredient in Trajenta, works by inhibiting the DPP-4 enzyme. This enzyme breaks down incretin hormones, which play a role in regulating blood sugar. By inhibiting DPP-4, linagliptin increases the levels of these hormones, leading to improved blood sugar control.